Lv13
20 积分 2025-12-03 加入
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer The Neotorch Randomized Clinical Trial
32分钟前
待确认
NeoSCORE II: three vs four cycles of neoadjuvant sintilimab + chemotherapy for squamous non-small-cell lung cancer
1小时前
已完结
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non–Small-Cell Lung Cancer
1小时前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IBIIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
1天前
已完结
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage nonsmall-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebocontrolled, phase 3 trial
1天前
已完结
Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial
1天前
已完结
求文章
1天前
已关闭
求文献
1天前
已完结
求文献
1天前
已完结
求文献
1天前
已完结
皖公网安备34019202002308
